| Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million … L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ... The lancet 390 (10113), 2627-2642, 2017 | 8902 | 2017 |
| Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 … B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ... The lancet 398 (10304), 957-980, 2021 | 2908 | 2021 |
| Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre … C Bachert, JK Han, M Desrosiers, PW Hellings, N Amin, SE Lee, J Mullol, ... The Lancet 394 (10209), 1638-1650, 2019 | 1286 | 2019 |
| Rising rural body-mass index is the main driver of the global obesity epidemic in adults Nature 569 (7755), 260-264, 2019 | 827 | 2019 |
| A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised … MP Boyle, SC Bell, MW Konstan, SA McColley, SM Rowe, E Rietschel, ... The lancet Respiratory medicine 2 (7), 527-538, 2014 | 546 | 2014 |
| Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based … A Rodriguez-Martinez, B Zhou, MK Sophiea, J Bentham, CJ Paciorek, ... The Lancet 396 (10261), 1511-1524, 2020 | 467 | 2020 |
| Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo … AS Paller, EC Siegfried, D Thaçi, A Wollenberg, MJ Cork, PD Arkwright, ... Journal of the American Academy of Dermatology 83 (5), 1282-1293, 2020 | 385 | 2020 |
| Dupilumab in adults and adolescents with eosinophilic esophagitis ES Dellon, ME Rothenberg, MH Collins, I Hirano, M Chehade, ... New England Journal of Medicine 387 (25), 2317-2330, 2022 | 327 | 2022 |
| Cell elasticity determines macrophage function NR Patel, M Bole, C Chen, CC Hardin, AT Kho, J Mih, L Deng, J Butler, ... Public Library of Science 7 (9), e41024, 2012 | 326 | 2012 |
| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 282 | 2021 |
| Blunt abdominal trauma: screening us in 2,693 patients MA Brown, G Casola, CB Sirlin, NY Patel, DB Hoyt Radiology 218 (2), 352-358, 2001 | 272 | 2001 |
| Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts SP Bhatt, KF Rabe, NA Hanania, CF Vogelmeier, J Cole, M Bafadhel, ... New England Journal of Medicine 389 (3), 205-214, 2023 | 258 | 2023 |
| Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ... The Lancet 396 (10246), e6-e7, 2020 | 251 | 2020 |
| Repositioning of the global epicentre of non-optimal cholesterol Nature 582 (7810), 73-77, 2020 | 244 | 2020 |
| Dupilumab in children with uncontrolled moderate-to-severe asthma LB Bacharier, JF Maspero, CH Katelaris, AG Fiocchi, R Gagnon, I de Mir, ... New England Journal of Medicine 385 (24), 2230-2240, 2021 | 221 | 2021 |
| Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial AS Paller, EL Simpson, EC Siegfried, MJ Cork, A Wollenberg, ... The Lancet 400 (10356), 908-919, 2022 | 189 | 2022 |
| HIV impairs TNF-α mediated macrophage apoptotic response to Mycobacterium tuberculosis NR Patel, J Zhu, SD Tachado, J Zhang, Z Wan, J Saukkonen, H Koziel The Journal of Immunology 179 (10), 6973-6980, 2007 | 170 | 2007 |
| Dupilumab provides favorable safety and sustained efficacy for up to 3 years in an open-label study of adults with moderate-to-severe atopic dermatitis LA Beck, D Thaçi, M Deleuran, A Blauvelt, R Bissonnette, ... American journal of clinical dermatology 21, 567-577, 2020 | 146 | 2020 |
| Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro J Zhang, SD Tachado, N Patel, J Zhu, A Imrich, P Manfruelli, M Cushion, ... Journal of leukocyte biology 78 (3), 665-674, 2005 | 142 | 2005 |
| Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY … WW Busse, SE Wenzel, TB Casale, JM FitzGerald, MS Rice, N Daizadeh, ... The Lancet Respiratory Medicine 9 (10), 1165-1173, 2021 | 138 | 2021 |
